Koyfin Home > Directory > Health Care > Inovio Pharma > EBITDA Margin

Inovio Pharma EBITDA Margin Chart (INO)

Inovio Pharma annual/quarterly EBITDA Margin from 2010 to 2020. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Inovio Pharma EBITDA Margin for the quarter ending June 06, 2020 was $-12,069m a 80.29% decrease of -9,689m year over year
  • Inovio Pharma EBITDA Margin for the last 12 months ending June 06, 2020 was $-3,894m a 58.16% decrease of -2,265m year over year
  • Inovio Pharma Annual EBITDA Margin for 2019 was $-2,542m a 88.50% decrease of -2,250m from 2018
  • Inovio Pharma Annual EBITDA Margin for 2018 was $-292m a 34.22% decrease of -100m from 2017
  • Inovio Pharma Annual EBITDA Margin for 2017 was $-192m a -9.04% increase of 17m from 2016
Other Margins & Efficiency Metrics:
  • Inovio Pharma Return on Capital % for the quarter ending December 12, 2018 was -77.33 a 17.16% decrease of -13.27 year over year
  • Inovio Pharma Return on Equity % for the quarter ending December 12, 2018 was -138.25 a 26.75% decrease of -36.99 year over year
View Chart On Koyfin

Quarterly INO EBITDA Margin Data

06/2020$-12,069m
03/2020$-1,830m
12/2019$-10,583m
09/2019$-2,379m
06/2019$-19,902m
03/2019$-966m
12/2018$-1,129m
09/2018$-1,272m
06/2018$-16m
03/2018$-2,056m

Annual INO EBITDA Margin Data

2019$-2,542m
2018$-292m
2017$-192m
2016$-210m
2015$-82m
2014$-363m
2013$-144m
2012$-550m
2011$-206m
2010$-278m